Nusinersen linked to improvements in upper limb strength, function

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Oct 12 / Springer Healthcare

Nusinersen linked to improvements in upper limb strength, function

Neuroscience Spinal Muscular Atrophy WMS-2022

Description

Evelin Milev talks about an observational study demonstrating improvements in upper limb function and muscle strength among children with type 2 or 3 spinal muscular atrophy treated with nusinersen.

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.